Literature DB >> 17098192

Proline and glycine control protein self-organization into elastomeric or amyloid fibrils.

Sarah Rauscher1, Stéphanie Baud, Ming Miao, Fred W Keeley, Régis Pomès.   

Abstract

Elastin provides extensible tissues, including arteries and skin, with the propensity for elastic recoil, whereas amyloid fibrils are associated with tissue-degenerative diseases, such as Alzheimer's. Although both elastin-like and amyloid-like materials result from the self-organization of proteins into fibrils, the molecular basis of their differing physical properties is poorly understood. Using molecular simulations of monomeric and aggregated states, we demonstrate that elastin-like and amyloid-like peptides are separable on the basis of backbone hydration and peptide-peptide hydrogen bonding. The analysis of diverse sequences, including those of elastin, amyloids, spider silks, wheat gluten, and insect resilin, reveals a threshold in proline and glycine composition above which amyloid formation is impeded and elastomeric properties become apparent. The predictive capacity of this threshold is confirmed by the self-assembly of recombinant peptides into either amyloid or elastin-like fibrils. Our findings support a unified model of protein aggregation in which hydration and conformational disorder are fundamental requirements for elastomeric function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098192     DOI: 10.1016/j.str.2006.09.008

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  92 in total

1.  Hydrophilic linkers and polar contacts affect aggregation of FG repeat peptides.

Authors:  Nicole Dölker; Ulrich Zachariae; Helmut Grubmüller
Journal:  Biophys J       Date:  2010-06-02       Impact factor: 4.033

2.  Mechanisms of protein oligomerization, the critical role of insertions and deletions in maintaining different oligomeric states.

Authors:  Kosuke Hashimoto; Anna R Panchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-03       Impact factor: 11.205

3.  Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery.

Authors:  Samagya Banskota; Parisa Yousefpour; Nadia Kirmani; Xinghai Li; Ashutosh Chilkoti
Journal:  Biomaterials       Date:  2018-11-28       Impact factor: 12.479

4.  Polyelectrostatic interactions of disordered ligands suggest a physical basis for ultrasensitivity.

Authors:  Mikael Borg; Tanja Mittag; Tony Pawson; Mike Tyers; Julie D Forman-Kay; Hue Sun Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-23       Impact factor: 11.205

Review 5.  Prevention of amyloid-like aggregation as a driving force of protein evolution.

Authors:  Elodie Monsellier; Fabrizio Chiti
Journal:  EMBO Rep       Date:  2007-08       Impact factor: 8.807

6.  NMR studies of localized water and protein backbone dynamics in mechanically strained elastin.

Authors:  Cheng Sun; Odingo Mitchell; Jiaxin Huang; Gregory S Boutis
Journal:  J Phys Chem B       Date:  2011-11-07       Impact factor: 2.991

7.  Prion Protein Prolines 102 and 105 and the Surrounding Lysine Cluster Impede Amyloid Formation.

Authors:  Allison Kraus; Kelsie J Anson; Lynne D Raymond; Craig Martens; Bradley R Groveman; David W Dorward; Byron Caughey
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

8.  The cytoplasmic domain of the T-cell receptor zeta subunit does not form disordered dimers.

Authors:  Amanda Nourse; Tanja Mittag
Journal:  J Mol Biol       Date:  2013-10-10       Impact factor: 5.469

9.  Conformational transitions of the cross-linking domains of elastin during self-assembly.

Authors:  Sean E Reichheld; Lisa D Muiznieks; Richard Stahl; Karen Simonetti; Simon Sharpe; Fred W Keeley
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

10.  Gatekeeper residues in the major curlin subunit modulate bacterial amyloid fiber biogenesis.

Authors:  Xuan Wang; Yizhou Zhou; Juan-Jie Ren; Neal D Hammer; Matthew R Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.